menu
    • menu

    Company profile for Progenity

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. We provide in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ProgenityUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4330 La Jolla Village Dr San Diego, CA 92122
    Telephone
    Telephone
    +1 855-293-2639
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.progenity.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/progenity-inc./
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/progenity

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biora, with spin on Xeljanz nearing the clinic, posts data
    Biora, with spin on Xeljanz nearing the clinic, posts data

    11 Jul 2022

    // Nick Paul Taylor FIERCEPHARMA

    https://www.fiercepharma.com/pharma/biora-spin-xeljanz-nearing-clinic-posts-data-its-targeted-gut-drug-delivery-device

    Nick Paul Taylor FIERCEPHARMA
    11 Jul 2022
    Share Share
    Progenity Announces Successful Transfer of Liquid Biopsy Technologies
    Progenity Announces Successful Transfer of Liquid Biopsy Technologies

    05 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/05/2436527/0/en/Progenity-Announces-Successful-Transfer-of-Liquid-Biopsy-Technologies.html

    GLOBENEWSWIRE
    05 May 2022
    Share Share
    Progenity to Report First Quarter Financial Results
    Progenity to Report First Quarter Financial Results

    03 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/03/2434675/0/en/Progenity-to-Report-First-Quarter-Financial-Results-and-Provide-Corporate-Update-as-Biora-Therapeutics-Inc.html

    GLOBENEWSWIRE
    03 May 2022
    Share Share
    Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s
    Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s

    25 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/25/2428218/0/en/Progenity-Appoints-Paul-Shabram-to-Lead-Technical-Operations-of-the-Company-s-Ingestible-Drug-Device-Platforms.html

    GLOBENEWSWIRE
    25 Apr 2022
    Share Share
    Progenity to Become Biora Therapeutics as it Completes Transformation
    Progenity to Become Biora Therapeutics as it Completes Transformation

    12 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/12/2421089/0/en/Progenity-to-Become-Biora-Therapeutics-as-it-Completes-Transformation.html

    GLOBENEWSWIRE
    12 Apr 2022
    Share Share
    Progenity Announces Two Poster Presentations at Controlled Release Society 2022
    Progenity Announces Two Poster Presentations at Controlled Release Society 2022

    06 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/06/2417676/0/en/Progenity-Announces-Two-Poster-Presentations-at-Controlled-Release-Society-2022.html

    GLOBENEWSWIRE
    06 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search